References
- Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am. 2019;103(3):463–473.
- Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24.
- Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
- Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565.
- Di X, Jin X, Li R, et al. CircRNAs and lung cancer: biomarkers and master regulators. Life Sci. 2019; 220:177–185.
- Wang C, Tan S, Li J, et al. CircRNAs in lung cancer – biogenesis, function and clinical implication. Cancer Lett. 2020; 492:106–115.
- Gao J, Ding C, Zhou J, et al. Propofol suppresses lung cancer tumorigenesis by modulating the circ-ERBB2/miR-7-5p/FOXM1 axis. Thorac Cancer. 2021;12(6):824–834.
- Li H, He L, Tuo Y, et al. Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis. BMC Cancer. 2020;20(1):1026.
- Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207.
- Iqbal MA, Arora S, Prakasam G, et al. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 2019;70:3–20.
- Wu KL, Tsai YM, Lien CT, et al. The roles of MicroRNA in lung cancer. IJMS. 2019;20(7):1611.
- Zhang F, Cheng R, Li P, et al. Hsa_circ_0010235 functions as an oncogenic drive in non-small cell lung cancer by modulating miR-433-3p/TIPRL axis. Cancer Cell Int. 2021;21(1):73.
- Cao S, Li L, Li J, et al. MiR-1299 impedes the progression of non-small-cell lung cancer through EGFR/PI3K/AKT signaling pathway. Onco Targets Ther. 2020;13:7493–7502.
- Yu H, Boyle TA, Zhou C, et al. PD-L1 expression in lung cancer. J Thorac Oncol. 2016;11(7):964–975.
- Wang CJ, Zhu CC, Xu J, et al. The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 2019;18(1):115.
- Huang X, Zhang W, Shao Z. Prognostic and diagnostic significance of circRNAs expression in lung cancer. J Cell Physiol. 2019;234(10):18459–18465.
- Chen B, Huang S. Circular RNA: an emerging non-coding RNA as a regulator and biomarker in cancer. Cancer Lett. 2018;418:41–50.
- Drula R, Braicu C, Harangus A, et al. Critical function of circular RNAs in lung cancer. Wiley Interdiscip Rev Rna. 2020;11(5):e1592.
- Pan J, Huang G, Yin Z, et al. Circular RNA FLNA acts as a sponge of miR-486-3p in promoting lung cancer progression via regulating XRCC1 and CYP1A1. Cancer Gene Ther. 2021;1–21.
- Ma Q, Huai B, Liu Y, et al. Circular RNA circ_0020123 promotes non-small cell lung cancer progression through miR-384/TRIM44 axis. Cancer Manag Res. 2021;13:75–87.
- Jin X, Guan Y, Sheng H, et al. Crosstalk in competing endogenous RNA network reveals the complex molecular mechanism underlying lung cancer. Oncotarget. 2017;8(53):91270–91280.
- Zhang L, Sun D, Zhang J, et al. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis. Life Sci. 2021;266:118829.
- Zhao L, Liu T, Zhang X, et al. lncRNA RHPN1-AS1 promotes ovarian cancer growth and invasiveness through inhibiting miR-1299. Onco Targets Ther. 2020;13:5337–5344.
- Li P, Wang Z, Li S, et al. Circ_0006404 accelerates prostate cancer progression through regulating miR-1299/CFL2 signaling. Onco Targets Ther. 2021;14:83–95.
- Li F, Zhu T, Yue Y, et al. Preliminary mechanisms of regulating PDL1 expression in nonsmall cell lung cancer during the EMT process. Oncol Rep. 2018;40(2):775–782.
- Du Z, Niu S, Wang J, et al. SChLAP1 contributes to non-small cell lung cancer cell progression and immune evasion through regulating the AUF1/PD-L1 axis. Autoimmunity. 2021;54(4):225–233.
- Wang H, Yan Z, Hao J, et al. CD137 ligand feedback upregulates PD-L1 expression on lung cancer via T cell production of IFN-γ. Thorac Cancer. 2019;10(12):2225–2235.